[Form 4] HARTFORD INSURANCE GROUP, INC. Insider Trading Activity
Rhea-AI Filing Summary
Hartford Insurance Group, Inc. executive vice president and chief financial officer Mary Ellen Costello reported stock transactions in the company’s shares. On 01/02/2026, she exercised a stock option to acquire 35,339 shares of common stock at an exercise price of $48.89 per share and then sold shares the same day in two transactions under a pre‑arranged Rule 10b5-1 trading plan adopted on August 4, 2025.
The reported sales were 11,368 shares at a weighted average price of $137.037 per share and 23,971 shares at a weighted average price of $136.3704 per share. After these transactions, she beneficially owned 101,544.606 shares before the second sale and 77,573.606 shares of common stock directly. The filing also lists multiple outstanding stock option grants with various exercise prices and expiration dates.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option | 35,339 | $0.00 | -- |
| Exercise | Common Stock | 35,339 | $48.89 | $1.73M |
| Sale | Common Stock | 11,368 | $137.037 | $1.56M |
| Sale | Common Stock | 23,971 | $136.3704 | $3.27M |
| holding | Stock Option | -- | -- | -- |
| holding | Stock Option | -- | -- | -- |
| holding | Stock Option | -- | -- | -- |
| holding | Stock Option | -- | -- | -- |
| holding | Stock Option | -- | -- | -- |
| holding | Stock Option | -- | -- | -- |
| holding | Stock Option | -- | -- | -- |
| holding | Stock Option | -- | -- | -- |
Footnotes (1)
- The transaction reported on this Form 4 was effected pursuant to a trading plan previously adopted by Ms. Costello on August 4, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. Price reflected is the weighted average sale price for shares sold. The range of sales prices for the transactions reported was $136.90 - $137.19 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Price reflected is the weighted average sale price for shares sold. The range of sales prices for the transactions reported was $135.90 - $136.90 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. The options became fully exercisable on February 28, 2020, the third anniversary of the grant date. The options became fully exercisable on February 26, 2022, the third anniversary of the grant date. The options became fully exercisable on February 23, 2024, the third anniversary of the grant date. The options became fully exercisable on February 27, 2021, the third anniversary of the grant date. The options became fully exercisable on February 25, 2023, the third anniversary of the grant date. The options became fully exercisable on February 23, 2025, the third anniversary of the grant date. One-third of the options became exercisable on February 28, 2024, an additional one-third of the options became exercisable on February 28, 2025 and the remaining one-third of the options will become exercisable on February 28, 2026, the third anniversary of the grant date. One-third of the options became exercisable on February 27, 2025, an additional one-third of the options will become exercisable on February 27, 2026 and the remaining one-third of the options will become exercisable on February 27, 2027, the third anniversary of the grant date. One-third of the options will become exercisable on February 25, 2026, an additional one-third of the options will become exercisable on February 25, 2027 and the remaining one-third of the options will become exercisable on February 25, 2028, the third anniversary of the grant date.